Get the Flex Certified solution
Providers must review all concurrent medications, as GLP-1 agonists can potentiate the effect of other glucose-lowering agents, requiring insulin or sulfonylurea dose reductions during transition
The landscape of prescription weight loss medications is dynamic, with the most commonly prescribed drug evolving over time
Switching from semaglutide to tirzepatide (while staying on metformin) If you are on metformin plus semaglutide and switching to tirzepatide, the transition is relatively straightforward
Second, although numerous observational studies have shown causal associations between TMAO and cardiovascular, kidney, neurological, and metabolic diseases, due to the inherent limitations of statistical methods (bias due to confounding factors and reverse causality), and the causal relationship between TMAO and human diseases still requires validation through multicenter, multi-ethnic randomized controlled trials
The activation status of DCs is deeply coupled to their metabolic pattern shifts, when DCs switch from quiescence to maturation upon antigen stimulation, metabolic conversion is required to generate energy and macromolecules from nutrients to match functional demands
